Preferred Name

Zoledronic Acid Anhydrous

Synonyms
Definitions

Anhydrous form of a synthetic imidazole third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate (diphosphate) synthase, thereby preventing protein prenylation within the mevalonate pathway. This leads to the loss of downstream metabolites essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, zoledronate decreases bone turnover and stabilizes the bone matrix.

ID

http://purl.obolibrary.org/obo/NCIT_C80120

CAS_Registry

118072-93-8

CHEBI_ID

CHEBI:46557

Chemical_Formula

C5H10N2O7P2

code

C80120

Contributing_Source

FDA

definition

Anhydrous form of a synthetic imidazole third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate (diphosphate) synthase, thereby preventing protein prenylation within the mevalonate pathway. This leads to the loss of downstream metabolites essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, zoledronate decreases bone turnover and stabilizes the bone matrix.

FDA_UNII_Code

70HZ18PH24

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

label

Zoledronic Acid Anhydrous

Legacy Concept Name

Zolendronic_Acid_Anhydrous

Preferred_Name

Zoledronic Acid Anhydrous

prefixIRI

NCIT:C80120

prefLabel

Zoledronic Acid Anhydrous

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C2700334

subClassOf

http://purl.obolibrary.org/obo/NCIT_C443

Delete Subject Author Type Created
No notes to display